Eli Lilly and (LLY) has a market capitalization of $707B, based on 899.32M shares at a price of $786.13 (up 1.5% on Wednesday).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
January 2025 | $787.22 | 14,786,792 | 899,315,974 | $707,959,521,052.28 |
December 2024 | $772.00 | 67,169,212 | 905,000,000 | $698,660,000,000.00 |
November 2024 | $795.35 | 99,599,400 | 905,000,000 | $719,791,750,000.00 |
October 2024 | $828.37 | 68,789,500 | 905,000,000 | $749,673,130,500.00 |
September 2024 | $884.48 | 58,009,800 | 905,000,000 | $800,449,965,500.00 |
August 2024 | $958.43 | 79,125,600 | 905,000,000 | $867,381,503,000.00 |
July 2024 | $801.82 | 72,471,200 | 905,000,000 | $725,646,919,000.00 |
June 2024 | $902.62 | 50,498,700 | 904,200,000 | $816,150,631,560.00 |
May 2024 | $817.84 | 58,801,200 | 904,200,000 | $739,491,651,360.00 |
April 2024 | $777.40 | 57,412,200 | 904,200,000 | $702,920,830,260.00 |
March 2024 | $774.27 | 58,730,700 | 903,802,000 | $699,786,955,300.40 |
February 2024 | $750.11 | 76,659,600 | 903,802,000 | $677,946,760,730.80 |
January 2024 | $641.42 | 61,977,700 | 903,802,000 | $579,719,932,527.20 |
December 2023 | $579.14 | 56,866,900 | 949,379,000 | $549,823,448,997.90 |
November 2023 | $587.21 | 75,603,800 | 949,379,000 | $557,482,469,142.50 |
October 2023 | $549.32 | 71,880,000 | 949,379,000 | $521,515,910,292.80 |
September 2023 | $532.66 | 58,008,400 | 899,800,000 | $479,290,077,420.00 |
August 2023 | $549.59 | 71,148,400 | 899,800,000 | $494,521,891,820.00 |
July 2023 | $449.81 | 46,830,100 | 899,800,000 | $404,734,988,900.00 |
June 2023 | $464.08 | 56,772,400 | 902,700,000 | $418,929,348,960.00 |
May 2023 | $424.98 | 75,448,900 | 902,700,000 | $383,627,008,710.00 |
April 2023 | $390.71 | 56,102,100 | 902,700,000 | $352,695,541,860.00 |
March 2023 | $338.95 | 80,114,100 | 903,300,000 | $306,176,877,210.00 |
February 2023 | $307.17 | 66,671,100 | 903,300,000 | $277,468,919,250.00 |
January 2023 | $338.58 | 50,722,700 | 903,300,000 | $305,838,230,040.00 |
